Table 1.
Infant and maternal characteristics by infant intervention.
Figure 1.
SWEN and SD-NVP exposed HIV-infected infants diagnosed within the first six weeks of life with NVP-R.
SWEN = up to six weeks of extended-dose nevirapine; SD-NVP = single-dose nevirapine; NVP-R = nevirapine resistance. P-values generated using Fisher's exact test.
Table 2.
NVP-R mutations among SWEN and SD-NVP exposed infants.
Figure 2.
SWEN and SD-NVP exposed infants infected with HIV after six weeks of age through late-breastfeeding with NVP-R.
SWEN = up to six weeks of extended-dose nevirapine; SD-NVP = single-dose nevirapine; NVP-R = nevirapine resistance. P-values generated using Fisher's exact test.
Table 3.
Late breast-milk transmission of NVP-R HIV in seven mother-infant pairs.
Table 4.
Extent of persistence of NVP-R mutations in SWEN and SD-NVP exposed infants.